BridgeMD
New treatment option for Autism Spectrum Disorder
Official title Peer Interventions for Preschoolers With Autism
ClinicalTrials.gov ID: NCT05799599
What this study is testing
- What it's testing
- This proposal will evaluate a series of peer-mediated interventions (PMIs) for preschool children (3 to 6 years) with ASD and limited or no spoken language, using an innovative Sequential Multiple Assignment Randomized Trial (SMART) design. Available evidence supports the beneficial effects of PMIs for improving social communication in children with ASD.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 6
You may be able to join if
- ASD diagnosis
- limited or no spoken language defined by less than 20 functional, spontaneous words
- currently using or a candidate for a speech-generating device
- access to peers without disabilities
- English as the primary language spoken at home
You likely can't join if
- co-morbid or major medical conditions other than ASD, based on caregiver and teacher report
- significant physical, sensory, or motor impairments that would prevent playing with another child
- uncorrected visual or hearing impairments that would cause difficulty following peer instructions
- a lack of symbol discrimination skills
The study team makes the final eligibility decision.
Where it's taking place
- Kansas City, Kansas, United States
- Chapel Hill, North Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 6 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kansas City, Kansas, United States; Chapel Hill, North Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.